Supplementary Table from Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with <i>NRAS</i>-mutant Melanoma

crossref(2023)

引用 0|浏览33
暂无评分
摘要
Supplementary Table from Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要